The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma
Mei Feng(Third People's Hospital of Chengdu), Yisheng Pan(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 25